XML 71 R59.htm IDEA: XBRL DOCUMENT v3.7.0.1
Segment and Geographical Information - Segment Revenue, Operating Income and Depreciation and Amortization (Detail) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Segment Reporting Information [Line Items]        
Revenue $ 17,790 $ 19,972 $ 53,054 $ 53,212
Operating income 1,743 6,597 6,688 12,776
Depreciation and amortization 1,405 1,406 4,006 3,703
Operating Segments [Member]        
Segment Reporting Information [Line Items]        
Operating income 3,633 8,346 12,549 18,123
Operating Segments [Member] | Medical Device [Member]        
Segment Reporting Information [Line Items]        
Revenue 12,778 15,654 39,260 39,500
Operating income 1,403 6,673 6,627 12,825
Depreciation and amortization 1,132 982 3,180 2,440
Operating Segments [Member] | In Vitro Diagnostics [Member]        
Segment Reporting Information [Line Items]        
Revenue 5,012 4,318 13,794 13,712
Operating income 2,230 1,673 5,922 5,298
Depreciation and amortization 103 222 309 647
Corporate [Member]        
Segment Reporting Information [Line Items]        
Operating income (1,890) (1,749) (5,861) (5,347)
Depreciation and amortization $ 170 $ 202 $ 517 $ 616